U.S. Department of Defense
On July 26, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $64.6 million contract modification to SiO2 Medical Products to increase domestic production of pharmaceutical vials made of hybrid, glass-equivalent materials.
This domestic industrial base expansion effort will allow SiO2 to design, develop, and build a series of three vial production systems in Auburn, Alabama.
This effort will increase vial production to 10 million vials per month by July 2024.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
